evergreening
Extending a drug's exclusivity by obtaining new patents on minor modifications so the protection is perpetually renewed ('forever green').
As defined in Robin Feldman on Drug Patents, Generics, and Drug Wars
Other definitions
Practice of making minor changes to a drug and reapplying for patents to extend protection beyond the original term.
Bill Gurley & Michael Mauboussin - Putting Theory into Practice - [Invest Like the Best, EP.370]
Where it comes up · 3
- Charles Calomiris on Capital Requirements, Leverage, and Financial Regulation3 claims
- Robin Feldman on Drug Patents, Generics, and Drug Wars2 claims
- Bill Gurley & Michael Mauboussin - Putting Theory into Practice - [Invest Like the Best, EP.370]1 claim
Most important claims · 6 of 6Search all claims for “evergreening” →
- In the Asacol/Delzicol case the company introduced a new patented product identical to the old drug except for an ineffective capsule that did nothing, then withdrew the original Asacol from the market; because pharmacists could not substitute a generic of the now-unavailable original, and generics could not add a matching capsule without infringing the new patent, the maneuver blocked generic competition despite the change being therapeutically meaningless.Robin Feldman on Drug Patents, Generics, and Drug Wars
- Within Hatch-Waxman, companies practice evergreening and product hopping—making a minor modification to a drug's delivery, dosage, or form right as the patent expires, obtaining a new patent on the trivially changed version, and then withdrawing the old version so generics of the original cannot be substituted.Robin Feldman on Drug Patents, Generics, and Drug Wars
- A 17-year drug patent is too long, and drug companies make small changes to reapply patents to draw out protection, whereas software patents written like drug patents would bring the software industry to a halt.Bill Gurley & Michael Mauboussin - Putting Theory into Practice - [Invest Like the Best, EP.370]
- An old banking principle holds that the one thing you should never do with a borrower in a losing situation is simply give them more time without restrictions or a plan of action, because someone already underwater will use the extra time to take big risks since they have no downside. This is why forbearance and evergreening turn small losses into big losses.Charles Calomiris on Capital Requirements, Leverage, and Financial Regulation
- Unlike cash, capital is an accounting fiction: when asset losses occur they only appear on the books when recognized, so banks and their regulators can manipulate capital figures to mask losses for political purposes, which they almost always want to do during crises. This is why relying entirely on capital requirements is dangerous.Charles Calomiris on Capital Requirements, Leverage, and Financial Regulation
- Euphemistic multi-syllable finance terms like 'evergreening' (which invokes a beautiful forest) and 'forbearance' (a Biblical concept of God's patience) are noble-sounding labels that actually describe a conspiracy of lying to avoid recognizing loan losses, driven by bankers not wanting to raise capital and regulators finding recognition politically inconvenient.Charles Calomiris on Capital Requirements, Leverage, and Financial Regulation